Madridge Journal of Oncogenesis最新文献

筛选
英文 中文
Immune Checkpoint Inhibitors: A Step forward in Cancer Management 免疫检查点抑制剂:癌症治疗的新进展
Madridge Journal of Oncogenesis Pub Date : 2019-09-16 DOI: 10.18689/mjo-1000112
A. Signorile, M. Carratù
{"title":"Immune Checkpoint Inhibitors: A Step forward in Cancer Management","authors":"A. Signorile, M. Carratù","doi":"10.18689/mjo-1000112","DOIUrl":"https://doi.org/10.18689/mjo-1000112","url":null,"abstract":"Maria Rosaria Carratù1*, Maria Assunta Potenza1, Carmela Nacci1, Domenico De Rasmo2 and Anna Signorile3 1Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Policlinico, Piazza Giulio Cesare 11, Bari, Italy 2Institute of Biomembranes, Bioenergetics and Molecular Biotechnology, National Research Council (CNR), Bari, Italy 3 Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Policlinico, Piazza Giulio Cesare 11, Bari, Italy","PeriodicalId":419802,"journal":{"name":"Madridge Journal of Oncogenesis","volume":"389 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124799896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta-Endorphin - Novel Anti-Tumor Activity -内啡肽-新型抗肿瘤活性
Madridge Journal of Oncogenesis Pub Date : 2019-01-07 DOI: 10.18689/mjo-1000110
T. Shrihari
{"title":"Beta-Endorphin - Novel Anti-Tumor Activity","authors":"T. Shrihari","doi":"10.18689/mjo-1000110","DOIUrl":"https://doi.org/10.18689/mjo-1000110","url":null,"abstract":"Endorphins are endogenous morphine, neuropeptides produced in the pituitary gland. Beta-endorphin is an abundant endorphin, more potent than morphine, synthesized and stored in the anterior pituitary gland. Beta-endorphin, has got various mechanisms of actions such as analgesic activity, stress buster activity, anti-inflammatory activity, and immune stimulatory activity, because of these mechanisms of actions it can be useful in holistic preventive, therapeutic, health promotive and palliative management of cancer without adverse effects. This article highlights about the basic research findings of anti-tumor activity of beta-endorphin.","PeriodicalId":419802,"journal":{"name":"Madridge Journal of Oncogenesis","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125178588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
ALK Fusion Protein Expression in Lung Adenocarcinoma and its Correlation with EGFR Protein Expression 肺腺癌组织中ALK融合蛋白的表达及其与EGFR蛋白表达的相关性
Madridge Journal of Oncogenesis Pub Date : 2018-12-12 DOI: 10.18689/MJO-1000109
B. Ladani, B. Raiya, Nupur Patel, H. Vora
{"title":"ALK Fusion Protein Expression in Lung Adenocarcinoma and its Correlation with EGFR Protein Expression","authors":"B. Ladani, B. Raiya, Nupur Patel, H. Vora","doi":"10.18689/MJO-1000109","DOIUrl":"https://doi.org/10.18689/MJO-1000109","url":null,"abstract":"Aim: To determine ALK fusion protein and EGFR protein expression by Immunohistochemistry in lung adenocarcinoma. Materials and Method: In this retrospective study, ALK and EGFR expression was evaluated by immunohistochemistry in 101 Formalin Fixed Paraffin Embedded (FFPE) tissues of lung adenocarcinoma. Results: In this study 11% patients showed ALK fusion protein expression. In relation to clinical parameters, a higher positive expression was observed in patients with age <59, in male gender and tobacco users. Further, with pathological parameters a higher expression of ALK was observed in advanced stage and positive lymph node status. EGFR expression was noted in 72% patients. In relation to clinical parameters, higher EGFR expression was seen in patients with age >59 years, in male gender with tobacco habit. Further, with pathological parameters, a trend of higher EGFR expression was observed in patients with positive lymph node status (p=0.06). In this study 8% of patients had ALK and EGFR dual expression, which is uncommon. Conclusion: Small group of NSCLC patients harbour ALK rearrangements which are candidate for targeted therapy (Crizotinib). Moreover, co-expression of ALK with EGFR defines a specific subgroup of patients that needs distinct therapeutic strategies.","PeriodicalId":419802,"journal":{"name":"Madridge Journal of Oncogenesis","volume":"111 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134173108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can hENT1 Predict Survival in Locally Advanced Pancreatic Carcinoma Received Gemcitabine Monotherapy? hENT1能否预测局部晚期胰腺癌患者接受吉西他滨单药治疗后的生存率?
Madridge Journal of Oncogenesis Pub Date : 2018-11-30 DOI: 10.18689/mjo-1000108
H. Tawfik, Sarah Ahmed, E. Saad, W. M. Said
{"title":"Can hENT1 Predict Survival in Locally Advanced Pancreatic Carcinoma Received Gemcitabine Monotherapy?","authors":"H. Tawfik, Sarah Ahmed, E. Saad, W. M. Said","doi":"10.18689/mjo-1000108","DOIUrl":"https://doi.org/10.18689/mjo-1000108","url":null,"abstract":"Background: Pancreatic cancer is a very aggressive disease. 5-year survival rates remain low at 10% to 30% even with adjuvant therapy, as most patients will succumb to the disease secondary to high rate of local and systemic recurrences. Gemcitabine is one of the drugs of choice for the adjuvant treatment for patients with pancreatic cancer. The drug is transported into pancreatic cancer cells primarily by human equilibrative nucleoside transporter 1 (hENT1). Aim: The aim of this study was to assess and evaluate the predictive and prognostic value of hENT1 expression in advanced pancreatic cancer patients. Methods: prospective and retrospective study was conducted on 30 patients presented with advanced pancreatic cancer; Immuno-histochemical staining of tumor tissue was performed for detecting hENT1 expression. All the patients have been treated with gemcitabine based chemotherapy. Results: Sixty percent of patients had high hENT1 expression and 40% had low hENT1 expression. Overall survival after median follow up of 14 months showed that patients with high hENT1 expression had longer Overall survival than patients with low hENT1 expression and the difference was statistically significant (p=0.001) and (p=0.0025) respectively. Further, patients with high hENT1 expression showed longer disease free survival than patients with low hENT1 expression, and the difference was statistically significant (p=0.002). Conclusions: A high level of hENT1 expression is significantly associated with a longer survival in patients who received gemcitabine mono therapy. Hence, the study suggests hENT1 expression as potential assay for the prediction of response to gemcitabine based chemotherapy.","PeriodicalId":419802,"journal":{"name":"Madridge Journal of Oncogenesis","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131051738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein Expression of DNA Damage Signaling Molecules in Patients with Oral Squamous Cell Carcinoma 口腔鳞状细胞癌患者DNA损伤信号分子的蛋白表达
Madridge Journal of Oncogenesis Pub Date : 2018-07-09 DOI: 10.18689/MJO-1000107
Jigna S Joshi, H. Vora, N. Ghosh, J. Goswami, T. Trivedi
{"title":"Protein Expression of DNA Damage Signaling Molecules in Patients with Oral Squamous Cell Carcinoma","authors":"Jigna S Joshi, H. Vora, N. Ghosh, J. Goswami, T. Trivedi","doi":"10.18689/MJO-1000107","DOIUrl":"https://doi.org/10.18689/MJO-1000107","url":null,"abstract":"Jigna S Joshi1, Hemangini H Vora2, Nandita R Ghosh3, Jignesh V Goswami4 and Trupti Trivedi1* 1Clinical Carcinogenesis Lab, Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India 2Immunohematology Lab, Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India 3Tumor biology Lab, Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India 4Department of Surgical Oncology, Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India","PeriodicalId":419802,"journal":{"name":"Madridge Journal of Oncogenesis","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127291901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书